Prognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG)

被引：0
|
作者：
Ip, H. N. N. [1 ]
Hwang, I. [2 ]
Kang, J. [2 ]
Kim, K-P. [2 ]
Jeong, J. H. [2 ]
Chang, H-M. [2 ]
Ryoo, B-Y. [2 ]
Yoo, C. [2 ]
机构：
[1] Chinese Univ Hong Kong, Med, Hong Kong, Peoples R China
[2] Asan Med Ctr, Oncol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
193P
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [1] Prognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG)
    Hwang, I.
    Kang, J.
    Yoo, C.
    Jeong, J. H.
    Kim, K-P.
    Chang, H-M.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores
    Hwang, Inhwan
    Kang, Jihoon
    Ip, Hei Nga Natalie
    Jeong, Jae Ho
    Kim, Kyu-pyo
    Chang, Heung-Moon
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 584 - 590
  • [3] Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores
    Inhwan Hwang
    Jihoon Kang
    Hei Nga Natalie Ip
    Jae Ho Jeong
    Kyu-pyo Kim
    Heung-Moon Chang
    Changhoon Yoo
    Baek-Yeol Ryoo
    Investigational New Drugs, 2019, 37 : 584 - 590
  • [4] Prognostic value of inflammation-based scores for patients treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
    Harada, K.
    Nakano, S.
    Saito, R.
    Ito, K.
    Kawamoto, Y.
    Nakatsumi, H.
    Yuki, S.
    Sakamoto, N.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S126 - S126
  • [5] Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin
    Hyungwoo Cho
    Changhoon Yoo
    Kyu-pyo Kim
    Jae Ho Jeong
    Jihoon Kang
    Heung-Moon Chang
    Sang Soo Lee
    Do Hyun Park
    Tae Jun Song
    Sung Koo Lee
    Myung-Hwan Kim
    Han Chu Lee
    Young-Suk Lim
    Kang Mo Kim
    Ju Hyun Shim
    Shin Hwang
    Gi-Won Song
    Deok-Bog Moon
    Jae Hoon Lee
    Young-Joo Lee
    Baek-Yeol Ryoo
    Investigational New Drugs, 2018, 36 : 496 - 502
  • [6] Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin
    Cho, Hyungwoo
    Yoo, Changhoon
    Kim, Kyu-pyo
    Jeong, Jae Ho
    Kang, Jihoon
    Chang, Heung-Moon
    Lee, Sang Soo
    Park, Do Hyun
    Song, Tae Jun
    Lee, Sung Koo
    Kim, Myung-Hwan
    Lee, Han Chu
    Lim, Young-Suk
    Kim, Kang Mo
    Shim, Ju Hyun
    Hwang, Shin
    Song, Gi-Won
    Moon, Deok-Bog
    Lee, Jae Hoon
    Lee, Young-Joo
    Ryoo, Baek-Yeol
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (03) : 496 - 502
  • [7] Safety and efficacy of first-line gemcitabine plus nab-paclitaxel for elderly metastatic pancreatic cancer patients
    Pecora, I.
    Vivaldi, C.
    Rovesti, G.
    Catanese, S.
    Salani, F.
    Gardini, A. Casadei
    Massa, V.
    Bernardini, L.
    Riggi, M.
    Andrikou, K.
    Rapposelli, I.
    Formica, V.
    Cesario, S.
    Caccese, M.
    Lencioni, M.
    Vasile, E.
    Falcone, A.
    Fornaro, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S151 - S151
  • [8] FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer
    Ay, Seval
    Atci, Muhammed Mustafa
    Arikan, Rukiye
    Dulgar, Ozgecan
    Ozyukseler, Deniz Tataroglu
    Paksoy, Nail
    Dogan, Izzet
    Oztosun, Bugra
    Tastekin, Didem
    Oven, Basak Bala
    Gumus, Mahmut
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (07) : 465 - 471
  • [9] First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
    Vivaldi, Caterina
    Salani, Francesca
    Rovesti, Giulia
    Pecora, Irene
    Catanese, Silvia
    Casadei-Gardini, Andrea
    Massa, Valentina
    Bernardini, Laura
    Riggi, Laura
    Andrikou, Kalliopi
    Rapposelli, Giovanni I.
    Formica, Vincenzo
    Lencioni, Monica
    Falcone, Alfredo
    Vasile, Enrico
    Fornaro, Lorenzo
    EUROPEAN JOURNAL OF CANCER, 2020, 137 : 108 - 116
  • [10] Prognostic implication of inflammation-based prognostic scores in patients with intrahepatic cholangiocarcinoma (iCCA) treated with first-line Gemcitabine plus Cisplatin (GEMCIS)
    Cho, H.
    Yoo, C.
    Kim, K-P.
    Chang, H-M.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2017, 28
12345